2023 Vol.41, N°4 - Table of contents
April - Vasculitis 2023
One year in review
CER16747
2023,41,4
Pg. 0765-0773
Free to view
Systemic vasculitis: one year in review 2023
M. Moretti, E. Treppo, S. Monti, G. La Rocca, G. Del Frate, P. Delvino, N. Italiano, F. Di Cianni, F. D'alessandro, R. Talarico, F. Ferro, L. Quartuccio, C. Baldini
DOI: https://doi.org/10.55563/clinexprheumatol/zf4daj
M. Moretti, E. Treppo, S. Monti, G. La Rocca, G. Del Frate, P. Delvino, N. Italiano, F. Di Cianni, F. D'alessandro, R. Talarico, F. Ferro, L. Quartuccio, C. Baldini
DOI: https://doi.org/10.55563/clinexprheumatol/zf4daj
Editorials
CER16630
2023,41,4
Pg. 0774-0776
Free to view
Polymyalgia rheumatica: when should we suspect an underlying large vessel vasculitis?
M.A. González-Gay, E.F. Vicente-Rabaneda, E. Heras-Recuero, S. Castañeda
DOI: https://doi.org/10.55563/clinexprheumatol/3bozph
M.A. González-Gay, E.F. Vicente-Rabaneda, E. Heras-Recuero, S. Castañeda
DOI: https://doi.org/10.55563/clinexprheumatol/3bozph
CER16689
2023,41,4
Pg. 0777-0779
Free to view
Tocilizumab for giant cell arteritis: what is optimal?
M. Kaymakci, K.J. Warrington
DOI: https://doi.org/10.55563/clinexprheumatol/u5tnbs
M. Kaymakci, K.J. Warrington
DOI: https://doi.org/10.55563/clinexprheumatol/u5tnbs
CER16700
2023,41,4
Pg. 0780-0783
Free to view
The targeted-biotherapy revolution for vasculitis treatment: major advances but certain concerns persist
L. Guillevin
DOI: https://doi.org/10.55563/clinexprheumatol/r5j8ci
L. Guillevin
DOI: https://doi.org/10.55563/clinexprheumatol/r5j8ci
CER16713
2023,41,4
Pg. 0784-0786
Free to view
The importance of defining which Janus kinases are activated in giant cell arteritis
M. Bonacini, A. Rossi, I. Ferrigno, F. Muratore, C. Salvarani, S. Croci
DOI: https://doi.org/10.55563/clinexprheumatol/u7elc2
M. Bonacini, A. Rossi, I. Ferrigno, F. Muratore, C. Salvarani, S. Croci
DOI: https://doi.org/10.55563/clinexprheumatol/u7elc2
Full Papers
CER15692
2023,41,4
Pg. 0787-0791
Free to view
COVID-19 vaccination rate and safety profile in a multicentre Italian population affected by mixed cryoglobulinaemic vasculitis
C. Vacchi, S. Testoni, M. Visentini, R. Zani, G. Lauletta, L. Gragnani, D. Filippini, C. Mazzaro, P. Fraticelli, L. Quartuccio, R. Padoan, L. Castelnovo, A.L. Zignego, C. Ferri, S. Scarpato, M. Casato, A. Hoxha, C. Salvarani, G. Monti, M. Galli, M. Sebastiani
DOI: https://doi.org/10.55563/clinexprheumatol/ldv88a
C. Vacchi, S. Testoni, M. Visentini, R. Zani, G. Lauletta, L. Gragnani, D. Filippini, C. Mazzaro, P. Fraticelli, L. Quartuccio, R. Padoan, L. Castelnovo, A.L. Zignego, C. Ferri, S. Scarpato, M. Casato, A. Hoxha, C. Salvarani, G. Monti, M. Galli, M. Sebastiani
DOI: https://doi.org/10.55563/clinexprheumatol/ldv88a
CER15613
2023,41,4
Pg. 0792-0799
Free to view
Application of the 2022 ACR/EULAR criteria for microscopic polyangiitis to patients with previously diagnosed microscopic polyangiitis
J.Y. Pyo, S.S. Ahn, J.J. Song, Y.-B. Park, S.-W. Lee
DOI: https://doi.org/10.55563/clinexprheumatol/vmrk76
J.Y. Pyo, S.S. Ahn, J.J. Song, Y.-B. Park, S.-W. Lee
DOI: https://doi.org/10.55563/clinexprheumatol/vmrk76
CER15799
2023,41,4
Pg. 0800-0811
Free to view
Clinical characteristics, brain magnetic resonance imaging findings and diagnostic approach of the primary central nervous system vasculitis according to angiographic classification
T. Shimoyama, K. Uchino, L.H. Calabrese, R.A. Hajj-Ali
DOI: https://doi.org/10.55563/clinexprheumatol/a9886f
T. Shimoyama, K. Uchino, L.H. Calabrese, R.A. Hajj-Ali
DOI: https://doi.org/10.55563/clinexprheumatol/a9886f
CER15827
2023,41,4
Pg. 0812-0820
Free to view
Do statins decrease vascular inflammation in patients at risk for large-vessel vasculitis? A retrospective observational study with FDG-PET/CT in polymyalgia rheumatica, giant cell arteritis and fever of unknown origin
F. Iannuzzi, E. Hysa, D. Camellino, S. Morbelli, M. Bauckneht, G. Sambuceti, M. Cutolo, M.A. Cimmino
DOI: https://doi.org/10.55563/clinexprheumatol/uq9p1q
F. Iannuzzi, E. Hysa, D. Camellino, S. Morbelli, M. Bauckneht, G. Sambuceti, M. Cutolo, M.A. Cimmino
DOI: https://doi.org/10.55563/clinexprheumatol/uq9p1q
CER15774
2023,41,4
Pg. 0821-0828
Free to view
Interstitial lung disease in microscopic polyangiitis and granulomatosis with polyangiitis: demographic, clinical, serological and radiological features of an Italian cohort from the Italian Society for Rheumatology
A. Manfredi, G. Cassone, R. Izzo, G. Dallagiacoma, M. Felicetti, A. Cariddi, A. Berti, A. Giollo, C. Nannini, S. Bettio, S. Monti, E. Conticini, M. Govoni, L. Quartuccio, L.M. Argolini, S. Kaleci, G. Emmi, C. Dejaco, R. Padoan, L. Dagna, M. Rossini, F. Cantini, C. Montecucco, B. Frediani, S. De Vita, R. Caporali, F. Muratore, M. Sebastiani, C. Salvarani
Collaborator/s: F. Schiavon, E. Marasco, A. Gattamelata, R. Bortolotti, D. Malandrino, B. Maranini
Study Group of the Italian Society for Rheumatology (SIR)
DOI: https://doi.org/10.55563/clinexprheumatol/xu4hmh
A. Manfredi, G. Cassone, R. Izzo, G. Dallagiacoma, M. Felicetti, A. Cariddi, A. Berti, A. Giollo, C. Nannini, S. Bettio, S. Monti, E. Conticini, M. Govoni, L. Quartuccio, L.M. Argolini, S. Kaleci, G. Emmi, C. Dejaco, R. Padoan, L. Dagna, M. Rossini, F. Cantini, C. Montecucco, B. Frediani, S. De Vita, R. Caporali, F. Muratore, M. Sebastiani, C. Salvarani
Collaborator/s: F. Schiavon, E. Marasco, A. Gattamelata, R. Bortolotti, D. Malandrino, B. Maranini
Study Group of the Italian Society for Rheumatology (SIR)
DOI: https://doi.org/10.55563/clinexprheumatol/xu4hmh
CER15942
2023,41,4
Pg. 0829-0836
Free to view
Optimisation of tocilizumab therapy in giant cell arteritis. A multicentre real-life study of 471 patients
M. Calderón-Goercke, J. Loricera, C. Moriano, S. Castañeda, J. Narváez, V. Aldasoro, O. Maiz, R. Melero, J.I. Villa, P. Vela, S. Romero-Yuste, J.L. Callejas, E. De Miguel, E. Galíndez-Agirregoikoa, F. Sivera, J.C. Fernández-López, C. Galisteo, I. Ferraz-Amaro, J. Sanchéz-Martín, L. Sánchez-Bilbao, M.A. González-Gay, J.L. Hernández, R. Blanco
Collaborator/s: J.C. Nieto, J.R. De Dios, E. Fernández, I. De La Morena, P. Moya, R. Solans-Laqué, E. Pérez Pampín, J.L. Andreu, M. Revenga, E. Labrador, A. García-Valle, A. Gallego, C. Iñíguez, C. Hidalgo, N. Garrido-Puñal, R. López-González, J.A. Román-Ivorra, F.M. Ortiz-Sanjuán, J.P. Baldivieso-Achá, S. Manrique, P. Collado, E. Raya, V. Pinillos, F. Navarro, A. Olivé-Marqués, F.J. Toyos, M.L. Marena Rojas, A.J. Más, B. Arca, C. Ordas-Calvo, M.D. Boquet, N. Álvarez-Rivas, M.L. Velloso-Feijoo, C. Campos, Í. Rúa-Figueroa, A. García, C. Vázquez, P. Lluch, C. Torres, C. Luna, E. Becerra, N. Fernández-Llanio, A. Conesa, E. Salgado
on behalf of the Tocilizumab in Giant Cell Arteritis Spanish Collaborative Group
DOI: https://doi.org/10.55563/clinexprheumatol/oqs8u9
M. Calderón-Goercke, J. Loricera, C. Moriano, S. Castañeda, J. Narváez, V. Aldasoro, O. Maiz, R. Melero, J.I. Villa, P. Vela, S. Romero-Yuste, J.L. Callejas, E. De Miguel, E. Galíndez-Agirregoikoa, F. Sivera, J.C. Fernández-López, C. Galisteo, I. Ferraz-Amaro, J. Sanchéz-Martín, L. Sánchez-Bilbao, M.A. González-Gay, J.L. Hernández, R. Blanco
Collaborator/s: J.C. Nieto, J.R. De Dios, E. Fernández, I. De La Morena, P. Moya, R. Solans-Laqué, E. Pérez Pampín, J.L. Andreu, M. Revenga, E. Labrador, A. García-Valle, A. Gallego, C. Iñíguez, C. Hidalgo, N. Garrido-Puñal, R. López-González, J.A. Román-Ivorra, F.M. Ortiz-Sanjuán, J.P. Baldivieso-Achá, S. Manrique, P. Collado, E. Raya, V. Pinillos, F. Navarro, A. Olivé-Marqués, F.J. Toyos, M.L. Marena Rojas, A.J. Más, B. Arca, C. Ordas-Calvo, M.D. Boquet, N. Álvarez-Rivas, M.L. Velloso-Feijoo, C. Campos, Í. Rúa-Figueroa, A. García, C. Vázquez, P. Lluch, C. Torres, C. Luna, E. Becerra, N. Fernández-Llanio, A. Conesa, E. Salgado
on behalf of the Tocilizumab in Giant Cell Arteritis Spanish Collaborative Group
DOI: https://doi.org/10.55563/clinexprheumatol/oqs8u9
CER15802
2023,41,4
Pg. 0837-0847
Free to view
Circular RNA expression profiles and identification of hsa_circ_0028381 as a potential biomarker of anti-neutrophil cytoplasmic antibody-associated vasculitis
Y. Liu, X. Zhang, Z. Ji, L. Ma, H. Chen, L. Jiang
DOI: https://doi.org/10.55563/clinexprheumatol/1z9lsh
Y. Liu, X. Zhang, Z. Ji, L. Ma, H. Chen, L. Jiang
DOI: https://doi.org/10.55563/clinexprheumatol/1z9lsh
CER16092
2023,41,4
Pg. 0848-0855
Free to view
Anti-neutrophil cytoplasmic antibody patterns can predict clinical relapse in ANCA-associated vasculitis: overall population and subgroups
C. Jiang, J. Liu, H. Wang, H. Liu, Z. Fu, M. Li, X. Liu
DOI: https://doi.org/10.55563/clinexprheumatol/087jdd
C. Jiang, J. Liu, H. Wang, H. Liu, Z. Fu, M. Li, X. Liu
DOI: https://doi.org/10.55563/clinexprheumatol/087jdd
CER15845
2023,41,4
Pg. 0856-0863
Free to view
Long-term kidney outcome of patients with rheumatological diseases and antineutrophil cytoplasmic antibody-glomerulonephritis: comparison with a primitive ANCA-glomerulonephritis cohort
L. Locatelli, M. Calatroni, F. Reggiani, G.D. Bonelli, M. Gerosa, L.M. Argolini, B. Trezzi, N. Del Papa, C. Angelini, M.R. Pozzi, R.A. Sinico, G. Moroni
DOI: https://doi.org/10.55563/clinexprheumatol/csk834
L. Locatelli, M. Calatroni, F. Reggiani, G.D. Bonelli, M. Gerosa, L.M. Argolini, B. Trezzi, N. Del Papa, C. Angelini, M.R. Pozzi, R.A. Sinico, G. Moroni
DOI: https://doi.org/10.55563/clinexprheumatol/csk834
CER16146
2023,41,4
Pg. 0864-0869
Free to view
Cranial and extracranial large-vessel giant cell arteritis share a genetic pattern of interferon-gamma pathway
D. Prieto-Peña, F. Genre, V. Pulito-Cueto, J.G. Ocejo-Vinyals, B. Atienza-Mateo, A. Muñoz Jiménez, F. Ortiz-Sanjuán, S. Romero-Yuste, C. Moriano, E. Galindez-Agirregoikoa, I. Calvo, N. Ortego Centeno, N. Álvarez-Rivas, J.A. Miranda-Filloy, J.P. Baldivieso-Achá, R. Blanco, O. Gualillo, J. Martín, S. Castañeda, R. López-Mejías, S. Remuzgo-Martínez, M.A. González-Gay
DOI: https://doi.org/10.55563/clinexprheumatol/3cqh12
D. Prieto-Peña, F. Genre, V. Pulito-Cueto, J.G. Ocejo-Vinyals, B. Atienza-Mateo, A. Muñoz Jiménez, F. Ortiz-Sanjuán, S. Romero-Yuste, C. Moriano, E. Galindez-Agirregoikoa, I. Calvo, N. Ortego Centeno, N. Álvarez-Rivas, J.A. Miranda-Filloy, J.P. Baldivieso-Achá, R. Blanco, O. Gualillo, J. Martín, S. Castañeda, R. López-Mejías, S. Remuzgo-Martínez, M.A. González-Gay
DOI: https://doi.org/10.55563/clinexprheumatol/3cqh12
CER16008
2023,41,4
Pg. 0870-0878
Free to view
Characteristics of B cells and immunoglobulin profile in Takayasu's arteritis
W. Ci, T. Li, J. Du, W. Fang, D. Chen, L. Han, R. Dong, J. Cao, L. Pan
DOI: https://doi.org/10.55563/clinexprheumatol/98s4q1
W. Ci, T. Li, J. Du, W. Fang, D. Chen, L. Han, R. Dong, J. Cao, L. Pan
DOI: https://doi.org/10.55563/clinexprheumatol/98s4q1
CER16086
2023,41,4
Pg. 0879-0886
Free to view
Serum soluble interleukin-7 receptor alpha levels are negatively correlated with the simultaneous activity of antineutrophil cytoplasmic antibody-associated vasculitis
T. Yoon, J.Y. Pyo, S.S. Ahn, J.J. Song, Y.-B. Park, S.-W. Lee
DOI: https://doi.org/10.55563/clinexprheumatol/xi77r8
T. Yoon, J.Y. Pyo, S.S. Ahn, J.J. Song, Y.-B. Park, S.-W. Lee
DOI: https://doi.org/10.55563/clinexprheumatol/xi77r8
CER16171
2023,41,4
Pg. 0887-0892
Free to view
Comparison of long-term survival after endovascular treatment versus medical therapy in patients with Takayasu's arteritis and pulmonary artery stenosis
Z. Huang, F. Dong, M. Wang, F. Hu, X. Liu
DOI: https://doi.org/10.55563/clinexprheumatol/zbt5ad
Z. Huang, F. Dong, M. Wang, F. Hu, X. Liu
DOI: https://doi.org/10.55563/clinexprheumatol/zbt5ad
CER16198
2023,41,4
Pg. 0893-0901
Free to view
The predictive value of Berden’s classification versus renal risk score for renal survival of Chinese patients with myeloperoxidase-anti-neutrophil cytoplasmic antibody-associated glomerulonephritis
W. Kong, A. Ni, M. Wang, X. Huang, L. Chen, Y. Ma, J. Chen, F. Han
DOI: https://doi.org/10.55563/clinexprheumatol/ozkrr0
W. Kong, A. Ni, M. Wang, X. Huang, L. Chen, Y. Ma, J. Chen, F. Han
DOI: https://doi.org/10.55563/clinexprheumatol/ozkrr0
CER16237
2023,41,4
Pg. 0902-0909
Free to view
AMPK hyperactivity maintains the survival of vasculogenic T cells in patients with Takayasu’s arteritis
M. Sun, X. Zhang, Y. Hao, P. Yin, J. Hu, M. Zheng, Z. Wen, X. Liu, C. Wang
DOI: https://doi.org/10.55563/clinexprheumatol/th1an2
M. Sun, X. Zhang, Y. Hao, P. Yin, J. Hu, M. Zheng, Z. Wen, X. Liu, C. Wang
DOI: https://doi.org/10.55563/clinexprheumatol/th1an2
CER16238
2023,41,4
Pg. 0910-0915
Free to view
Cranial and extracranial giant cell arteritis do not exhibit differences in the IL6 -174 G/C gene polymorphism
F. Genre, D. Prieto-Peña, V. Pulito-Cueto, J.G. Ocejo-Vinyals, B. Atienza-Mateo, A. Muñoz Jiménez, F. Ortiz-Sanjuán, S. Romero-Yuste, C. Moriano, E. Galíndez-Agirregoikoa, I. Calvo, N. Ortego Centeno, N. Álvarez-Rivas, J.A. Miranda-Filloy, I. Llorente, R. Blanco, O. Gualillo, J. Martín, S. Castañeda, R. López-Mejías, S. Remuzgo-Martínez, M.A. González-Gay
DOI: https://doi.org/10.55563/clinexprheumatol/cbjnmo
F. Genre, D. Prieto-Peña, V. Pulito-Cueto, J.G. Ocejo-Vinyals, B. Atienza-Mateo, A. Muñoz Jiménez, F. Ortiz-Sanjuán, S. Romero-Yuste, C. Moriano, E. Galíndez-Agirregoikoa, I. Calvo, N. Ortego Centeno, N. Álvarez-Rivas, J.A. Miranda-Filloy, I. Llorente, R. Blanco, O. Gualillo, J. Martín, S. Castañeda, R. López-Mejías, S. Remuzgo-Martínez, M.A. González-Gay
DOI: https://doi.org/10.55563/clinexprheumatol/cbjnmo
CER16267
2023,41,4
Pg. 0916-0921
Free to view
Relationship between histopathological features of non-infectious aortitis and the results of pre-operative 18F-FDG-PET/CT: a retrospective study of 16 patients
S. Parreau, O. Espitia, M.S. Bold, L.M. Frota Lima, G. Lades, M. Bois, M. Assaraf, D. Saadoun, M.J. Koster, K.-H. Ly, C.M. Weyand, K.J. Warrington, E. Liozon
DOI: https://doi.org/10.55563/clinexprheumatol/5mevq4
S. Parreau, O. Espitia, M.S. Bold, L.M. Frota Lima, G. Lades, M. Bois, M. Assaraf, D. Saadoun, M.J. Koster, K.-H. Ly, C.M. Weyand, K.J. Warrington, E. Liozon
DOI: https://doi.org/10.55563/clinexprheumatol/5mevq4
CER16325
2023,41,4
Pg. 0922-0927
Free to view
Multicentre case-control study evaluating the safety of anti-SARS-CoV-2 vaccines in a cohort of patients with systemic vasculitis
E. Simoncelli, E. Conticini, S. Colafrancesco, A. Gattamelata, F.R. Spinelli, C. Garufi, S. Truglia, S. Grazzini, F. Giardina, R. Izzo, L. Cantarini, B. Frediani, F. Conti, R. Priori
DOI: https://doi.org/10.55563/clinexprheumatol/if8nka
E. Simoncelli, E. Conticini, S. Colafrancesco, A. Gattamelata, F.R. Spinelli, C. Garufi, S. Truglia, S. Grazzini, F. Giardina, R. Izzo, L. Cantarini, B. Frediani, F. Conti, R. Priori
DOI: https://doi.org/10.55563/clinexprheumatol/if8nka
CER16482
2023,41,4
Pg. 0928-0935
Free to view
ANCA-associated pulmonary-renal syndrome treated with cyclophosphamide, rituximab, repeated methyl-prednisolone pulses and a reduced oral glucocorticoid regime: an observational study
C. Gómez-Carballo, A. Soto-Peleteiro, M. Olmo-Velasco, L. Bueno, I. Ruiz-Arruza, G. Ruiz-Irastorza
DOI: https://doi.org/10.55563/clinexprheumatol/z39rsu
C. Gómez-Carballo, A. Soto-Peleteiro, M. Olmo-Velasco, L. Bueno, I. Ruiz-Arruza, G. Ruiz-Irastorza
DOI: https://doi.org/10.55563/clinexprheumatol/z39rsu
CER16317
2023,41,4
Pg. 0936-0942
Free to view
Spectrum of ANCA-specificities in eosinophilic granulomatosis with polyangiitis. A retrospective multicentre study
S. Arnold, J. Mahrhold, A. Kerstein-Staehle, G. Riemekasten, E. Csernok, B. Hellmich, N. Venhoff, J. Thiel, K. Affeldt, A. Jahnke, P. Lamprecht
DOI: https://doi.org/10.55563/clinexprheumatol/299yme
S. Arnold, J. Mahrhold, A. Kerstein-Staehle, G. Riemekasten, E. Csernok, B. Hellmich, N. Venhoff, J. Thiel, K. Affeldt, A. Jahnke, P. Lamprecht
DOI: https://doi.org/10.55563/clinexprheumatol/299yme
CER16594
2023,41,4
Pg. 0943-0947
Free to view
A Canadian vasculitis patient-driven survey to highlight which prednisone-related side effects matter the most
G.K. Yardimci, C. Pagnoux, J. Stewart
DOI: https://doi.org/10.55563/clinexprheumatol/ef9nda
G.K. Yardimci, C. Pagnoux, J. Stewart
DOI: https://doi.org/10.55563/clinexprheumatol/ef9nda
CER16446
2023,41,4
Pg. 0948-0955
Free to view
Soluble Tyro-3 and Axl may reflect the current activity and renal involvement in patients with microscopic polyangiitis and granulomatosis with polyangiitis
T.G. Lee, T. Yoon, E. Ko, J.Y. Pyo, S.S. Ahn, J.J. Song, Y.-B. Park, S.-W. Lee
DOI: https://doi.org/10.55563/clinexprheumatol/6pltaf
T.G. Lee, T. Yoon, E. Ko, J.Y. Pyo, S.S. Ahn, J.J. Song, Y.-B. Park, S.-W. Lee
DOI: https://doi.org/10.55563/clinexprheumatol/6pltaf
CER16604
2023,41,4
Pg. 0956-0960
Free to view
The epidemiology of pathologically confirmed clinically isolated aortitis: a North American population-based study
M. Kaymakci, M. Elfishawi, H.E. Langenfeld, C.S. Crowson, C.M. Weyand, M.J. Koster, K.J. Warrington
DOI: https://doi.org/10.55563/clinexprheumatol/3vdshi
M. Kaymakci, M. Elfishawi, H.E. Langenfeld, C.S. Crowson, C.M. Weyand, M.J. Koster, K.J. Warrington
DOI: https://doi.org/10.55563/clinexprheumatol/3vdshi
Case Report
CER16298
2023,41,4
Pg. 0961-0963
Free to view
18F-fluorodeoxyglucose positron emission tomography for the assessment of endo-bronchial involvement in granulomatosis with polyangiitis
C. Magro-Checa, S.T. Laurens, D. Goudkade, G.-J. Nobel-Hoff, R.L. Mostard
DOI: https://doi.org/10.55563/clinexprheumatol/szc6ma
C. Magro-Checa, S.T. Laurens, D. Goudkade, G.-J. Nobel-Hoff, R.L. Mostard
DOI: https://doi.org/10.55563/clinexprheumatol/szc6ma
Reviews
CER16676
2023,41,4
Pg. 0964-0974
Free to view
Goodpasture syndrome and anti-glomerular basement membrane disease
F. Reggiani, V. L'imperio, M. Calatroni, F. Pagni, R.A. Sinico
DOI: https://doi.org/10.55563/clinexprheumatol/tep3k5
F. Reggiani, V. L'imperio, M. Calatroni, F. Pagni, R.A. Sinico
DOI: https://doi.org/10.55563/clinexprheumatol/tep3k5
CER16727
2023,41,4
Pg. 0975-0981
Free to view
Pros and cons of TNF inhibitors and tocilizumab in the treatment of large-vessel vasculitis
C. Marvisi, C. Ricordi, E. Galli, F. Muratore, L. Boiardi, P.L. Macchioni, N. Pipitone, F. Macaluso, C. Salvarani, F. Brandolino
DOI: https://doi.org/10.55563/clinexprheumatol/cj4ea8
C. Marvisi, C. Ricordi, E. Galli, F. Muratore, L. Boiardi, P.L. Macchioni, N. Pipitone, F. Macaluso, C. Salvarani, F. Brandolino
DOI: https://doi.org/10.55563/clinexprheumatol/cj4ea8
Letters to the Editor
CER16336
2023,41,4
Pg. 0982-0983
Free to view
Vasculitis induced by Janus-kinase inhibitors: truth or illusion?
G. Wang, J. Li, Y. Luo, L. Xue, Z. Liu
DOI: https://doi.org/10.55563/clinexprheumatol/b5nms1
G. Wang, J. Li, Y. Luo, L. Xue, Z. Liu
DOI: https://doi.org/10.55563/clinexprheumatol/b5nms1
CER15644
2023,41,4
Pg. 0984
Free to view
Utility of lower extremity magnetic resonance imaging followed by muscle biopsy for myeloperoxidase-antineutrophil cytoplasmic antibodies positive antineutrophil cytoplasmic antibody-associated vasculitis: a single-centre study
S. Jinno, P.A. Monach, T. Nakazawa
DOI: https://doi.org/10.55563/clinexprheumatol/eqd0ch
S. Jinno, P.A. Monach, T. Nakazawa
DOI: https://doi.org/10.55563/clinexprheumatol/eqd0ch
CER15676
2023,41,4
Pg. 0985-0986
Free to view
Progression of large-vessel giant cell arteritis despite tocilizumab treatment
M. Elfishawi, M. Kaymakci, M.J. Koster, K.J. Warrington
DOI: https://doi.org/10.55563/clinexprheumatol/60vlze
M. Elfishawi, M. Kaymakci, M.J. Koster, K.J. Warrington
DOI: https://doi.org/10.55563/clinexprheumatol/60vlze
CER15985
2023,41,4
Pg. 0987
Free to view
Comment on: Vasculitis, fibromuscular dysplasia or hereditary aneurysms? by Marvisi et al.
A. Betrains, L. Moreel, S. Vanderschueren, D. Blockmans
DOI: https://doi.org/10.55563/clinexprheumatol/fdjbnn
A. Betrains, L. Moreel, S. Vanderschueren, D. Blockmans
DOI: https://doi.org/10.55563/clinexprheumatol/fdjbnn
CER16070
2023,41,4
Pg. 0988
Free to view
Reply to Comment on: Vasculitis, fibromuscular dysplasia or hereditary aneurysms? by Marvisi et al.
C. Marvisi, P. Castrignanò, G. Besutti, L. Spaggiari, A. Caruso, F. Muratore, C. Salvarani
DOI: https://doi.org/10.55563/clinexprheumatol/7nqjpf
C. Marvisi, P. Castrignanò, G. Besutti, L. Spaggiari, A. Caruso, F. Muratore, C. Salvarani
DOI: https://doi.org/10.55563/clinexprheumatol/7nqjpf
CER16534
2023,41,4
Pg. 0989-0990
Free to view
New-onset aortitis manifesting as relapsing giant cell arteritis successfully managed with tocilizumab monotherapy. A comment on: Optimisation of tocilizumab therapy in giant cell arteritis. A multicentre real-life study of 471 patients. by Calderon-Goerc
M. Guarda, P.A. Araoz, U. Ghaffar, K.J. Warrington, M.J. Koster
DOI: https://doi.org/10.55563/clinexprheumatol/032qke
M. Guarda, P.A. Araoz, U. Ghaffar, K.J. Warrington, M.J. Koster
DOI: https://doi.org/10.55563/clinexprheumatol/032qke
CER16562
2023,41,4
Pg. 0991
Free to view
Reply to: New-onset aortitis manifesting as relapsing giant cell arteritis successfully managed with tocilizumab monotherapy. by Guarda et al.
M.Á. González-Gay, J.L. Hernández, R. Blanco
DOI: https://doi.org/10.55563/clinexprheumatol/ht170k
M.Á. González-Gay, J.L. Hernández, R. Blanco
DOI: https://doi.org/10.55563/clinexprheumatol/ht170k